Anil Pareek

659 total citations
29 papers, 443 citations indexed

About

Anil Pareek is a scholar working on Pharmacology, Molecular Biology and Rheumatology. According to data from OpenAlex, Anil Pareek has authored 29 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 5 papers in Molecular Biology and 5 papers in Rheumatology. Recurrent topics in Anil Pareek's work include Inflammatory mediators and NSAID effects (6 papers), Diabetes Treatment and Management (5 papers) and Pain Mechanisms and Treatments (4 papers). Anil Pareek is often cited by papers focused on Inflammatory mediators and NSAID effects (6 papers), Diabetes Treatment and Management (5 papers) and Pain Mechanisms and Treatments (4 papers). Anil Pareek collaborates with scholars based in India, Saudi Arabia and United States. Anil Pareek's co-authors include Nitin Chandurkar, Anil Gupta, Ajay Chandanwale, Ashish Bhalla, Jasmina Ahluwalia, Nusrat Shafiq, Samir Malhotra, Navneet Agrawal, Om Prakash Katare and Gajanand Sharma and has published in prestigious journals such as Journal of the American College of Cardiology, Diabetes and International Journal of Pharmaceutics.

In The Last Decade

Anil Pareek

26 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anil Pareek India 12 115 97 61 56 54 29 443
Nitin Chandurkar India 12 109 0.9× 61 0.6× 84 1.4× 23 0.4× 20 0.4× 24 387
Amitabh Prakash New Zealand 11 69 0.6× 57 0.6× 16 0.3× 24 0.4× 64 1.2× 16 623
Hyewon Chung South Korea 16 50 0.4× 33 0.3× 65 1.1× 121 2.2× 15 0.3× 45 592
Jutta Miller United States 12 120 1.0× 31 0.3× 58 1.0× 37 0.7× 9 0.2× 20 483
Dennis H. Giesing United States 11 52 0.5× 62 0.6× 14 0.2× 25 0.4× 32 0.6× 18 479
M Zschiesche Germany 12 90 0.8× 21 0.2× 41 0.7× 44 0.8× 42 0.8× 44 764
Apichaya Puangpetch Thailand 16 255 2.2× 90 0.9× 26 0.4× 31 0.6× 7 0.1× 37 596
George Perentesis United States 9 63 0.5× 38 0.4× 29 0.5× 18 0.3× 16 0.3× 21 402
Dongseong Shin South Korea 11 45 0.4× 33 0.3× 44 0.7× 20 0.4× 14 0.3× 35 349
Christopher J. Needs Australia 9 100 0.9× 122 1.3× 13 0.2× 63 1.1× 12 0.2× 13 484

Countries citing papers authored by Anil Pareek

Since Specialization
Citations

This map shows the geographic impact of Anil Pareek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anil Pareek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anil Pareek more than expected).

Fields of papers citing papers by Anil Pareek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anil Pareek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anil Pareek. The network helps show where Anil Pareek may publish in the future.

Co-authorship network of co-authors of Anil Pareek

This figure shows the co-authorship network connecting the top 25 collaborators of Anil Pareek. A scholar is included among the top collaborators of Anil Pareek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anil Pareek. Anil Pareek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pareek, Anil, et al.. (2025). Phase 1 study of novel anti-platelet agent to overcome pharmacogenomic limitations of clopidogrel. Open Heart. 12(1). e003088–e003088.
2.
Pareek, Anil, et al.. (2025). Advancements in superparamagnetic nanogels: A dual-role platform for diagnosis and targeted drug delivery. International Journal of Pharmaceutics. 677. 125683–125683. 1 indexed citations
3.
Pareek, Anil, et al.. (2025). Review of engineered magnetic chitosan nanoparticles for drug delivery: Advances, challenges, and future prospects. International Journal of Biological Macromolecules. 327(Pt 2). 147441–147441. 1 indexed citations
4.
Kapoor, Devesh U., et al.. (2025). Reengineering infection treatment: Liposome-based innovations in antibacterial delivery. Results in Chemistry. 16. 102417–102417. 2 indexed citations
5.
Kapoor, Devesh U., Anil Pareek, Saraswati Patel, et al.. (2025). Advances in cancer therapy using fluorinated chitosan: a promising nanoplatform for drug delivery. Medical Oncology. 42(10). 452–452. 1 indexed citations
6.
Pareek, Anil, Vani Parmar, Glowi Alasiri, et al.. (2025). pH-Sensitive hydrogels for breast cancer therapy: Targeted drug delivery and controlled release approaches. International Journal of Pharmaceutics. 682. 125899–125899. 3 indexed citations
7.
Pareek, Anil, et al.. (2020). SGLT2 inhibitor/GLP-1 receptor agonists as first step monotherapy—evidence and implications. International Journal of Diabetes in Developing Countries. 40(4). 636–637. 1 indexed citations
8.
Pareek, Anil, Franz H. Messerli, Nitin Chandurkar, et al.. (2016). Efficacy of Low-Dose Chlorthalidone and Hydrochlorothiazide as Assessed by 24-h Ambulatory Blood Pressure Monitoring. Journal of the American College of Cardiology. 67(4). 379–389. 38 indexed citations
9.
Sharma, Gajanand, Jaspreet Singh, Mahesh Kumar, et al.. (2016). Aceclofenac: Species-Dependent Metabolism and Newer Paradigm Shift from Oral to Non-oral Delivery. Current Topics in Medicinal Chemistry. 17(2). 107–119. 7 indexed citations
10.
Ahluwalia, Jasmina, et al.. (2014). Hydroxychloroquine’s Efficacy as an Antiplatelet Agent Study in Healthy Volunteers. Journal of Cardiovascular Pharmacology and Therapeutics. 20(2). 174–180. 46 indexed citations
11.
Pareek, Anil, Nitin Chandurkar, Nihal Thomas, et al.. (2014). Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone. Current Medical Research and Opinion. 30(7). 1257–1266. 78 indexed citations
12.
Pareek, Anil, et al.. (2011). Comparative evaluation of efficacy and safety of etodolac and diclofenac sodium injection in patients with postoperative orthopedic pain. Current Medical Research and Opinion. 27(11). 2107–2115. 4 indexed citations
13.
Pareek, Anil, et al.. (2011). Evaluation of Efficacy and Tolerability of Glimepiride and Metformin Combination. American Journal of Therapeutics. 20(1). 41–47. 10 indexed citations
14.
15.
Pareek, Anil, et al.. (2010). Efficacy and safety of aceclofenac and drotaverine fixed-dose combination in the treatment of primary dysmenorrhoea: a double-blind, double-dummy, randomized comparative study with aceclofenac. European Journal of Obstetrics & Gynecology and Reproductive Biology. 152(1). 86–90. 16 indexed citations
16.
17.
18.
Pareek, Anil, Madhuri Kulkarni, Subhashchandra Daga, Anand Deshpande, & Nitin Chandurkar. (2008). Comparative evaluation of efficacy and safety of cefotaxime-sulbactam with amoxicillin-clavulanic acid in children with lower respiratory tract infections. Expert Opinion on Pharmacotherapy. 9(16). 2751–2757. 8 indexed citations
19.
Pareek, Anil, et al.. (2008). EVALUATION OF EFFICACY AND SAFETY OF CEFOTAXIME SODIUM AND SULBACTAM IN CHILDREN WITH LOWER RESPIRATORY TRACT INFECTIONS. 93. 1 indexed citations
20.
Pareek, Anil, et al.. (2006). EFFICACY AND SAFETY OF β-ARTEETHER AND α/β-ARTEETHER FOR TREATMENT OF ACUTE PLASMODIUM FALCIPARUM MALARIA. American Journal of Tropical Medicine and Hygiene. 75(1). 139–142. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nitin Chandurkar Breakdown of academic impact, for papers by Amitabh Prakash Breakdown of academic impact, for papers by Hyewon Chung Breakdown of academic impact, for papers by Jutta Miller Breakdown of academic impact, for papers by Dennis H. Giesing Breakdown of academic impact, for papers by M Zschiesche Breakdown of academic impact, for papers by Apichaya Puangpetch Breakdown of academic impact, for papers by George Perentesis Breakdown of academic impact, for papers by Dongseong Shin Breakdown of academic impact, for papers by Christopher J. Needs
Rankless by CCL
2026